Dr. Dinender Singla is a translational scientist. Our team investigates the role of stem cells and their derivative exosomes in anti-cancer drug-induced cardiac toxicities and diabetes-induced muscle myopathy and cardiomyopathy.
He is continuously serving to review the grants for various NIH, AHA, ministry of Italian Health, and Hong Kong study sections. He is an Academic Editor for PLos one, an Associate Editor for the Canadian Journal of Physiology and Pharmacology as well as he is serving as the Editorial board member for different journals such as the American Journal of Physiology: Heart and Circulatory. He served as a chair, TPIG committee, the American Physiology Society, and a general secretary for North American section of the International Academy of Cardiovascular Sciences. He is President of the international society for adaptive Medicine. He is a fellow international academy of cardiovascular sciences, the American Physiological Society, and the American Heart Association. He is a reviewer for different journals. He served as a chair for various scientific sessions throughout the world. He has also organized a scientific conference. He has published a book on stem cells and is an author/ coauthor for more than 100 peer-reviewed papers.